Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-28T10:04:15.862Z Has data issue: false hasContentIssue false

Prescribing restrictions for expensive psychiatric drugs

Published online by Cambridge University Press:  02 January 2018

C. Bottomley
Affiliation:
Chelsea and Westminster Hospital, London SW10 9NH
C. Hallstrom
Affiliation:
Charing Cross Hospital, London W6 8RF
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Davies, L. M. & Drummond, M. F. (1990) The economic burden of schizophrenia. Psychiatric Bulletin, 14, 522525.Google Scholar
Fitton, A. & Benfield, P. (1993) Clozapine: an appraisal of it's pharmacoeconomic benefits in the treatment of schizophrenia. Pharmacoeconomics, 4, 131156.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.